We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$41.7B
AUM Growth
+$2.19B
Cap. Flow
+$591M
Cap. Flow %
1.42%
Top 10 Hldgs %
9.51%
Holding
3,328
New
131
Increased
1,345
Reduced
1,491
Closed
336
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRR
1226
DELISTED
Carbo Ceramics Inc.
CRR
$4.72M 0.01%
79,674
-4,113
-5% -$469K
VALE.P
1227
DELISTED
Vale S A
VALE.P
$4.72M 0.01%
485,736
+24,247
+5% +$288K
BVN icon
1228
Compañía de Minas Buenaventura
BVN
$8.41B
$4.71M 0.01%
406,660
-52,623
-11% -$656K
UDR icon
1229
UDR
UDR
$12.4B
$4.7M 0.01%
172,377
+10,677
+7% +$309K
HSIC icon
1230
Henry Schein
HSIC
$10.1B
$4.68M 0.01%
102,388
-1,285
-1% -$59.6K
ITT icon
1231
ITT
ITT
$18.3B
$4.67M 0.01%
103,912
-32,725
-24% -$1.56M
NXPI icon
1232
CALL
NXP Semiconductors
NXPI
$58.8B
$4.64M 0.01%
+67,800
New +$4.51M
TBPH icon
1233
Theravance Biopharma
TBPH
$876M
$4.63M 0.01%
200,724
+261
+0.1% +$7.57K
HPF
1234
John Hancock Preferred Income Fund II
HPF
$344M
$4.62M 0.01%
230,871
-4,643
-2% -$93.7K
REG icon
1235
Regency Centers
REG
$14.4B
$4.61M 0.01%
85,611
+31,173
+57% +$1.74M
TU icon
1236
Telus
TU
$15B
$4.6M 0.01%
269,098
+254,298
+1,718% +$4.54M
SWKS icon
1237
Skyworks Solutions
SWKS
$10B
$4.6M 0.01%
79,210
-5,571
-7% -$297K
MWA icon
1238
Mueller Water Products
MWA
$4.12B
$4.59M 0.01%
554,420
+34,391
+7% +$298K
BID
1239
DELISTED
Sotheby's
BID
$4.57M 0.01%
128,024
-46,220
-27% -$1.82M
NAD icon
1240
Nuveen Quality Municipal Income Fund
NAD
$2.74B
$4.57M 0.01%
329,998
-29,264
-8% -$405K
NMZ icon
1241
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.19B
$4.56M 0.01%
350,007
+51,519
+17% +$668K
AGIO icon
1242
Agios Pharmaceuticals
AGIO
$1.89B
$4.54M 0.01%
74,002
+727
+1% +$31.3K
CHD icon
1243
Church & Dwight Co
CHD
$24.4B
$4.53M 0.01%
129,220
+7,724
+6% +$263K
ITC
1244
DELISTED
ITC HOLDINGS CORP
ITC
$4.51M 0.01%
126,693
+13,405
+12% +$487K
MPT
1245
Medical Properties Trust
MPT
$2.75B
$4.51M 0.01%
367,809
+81,364
+28% +$1.08M
GEVA
1246
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$4.51M 0.01%
65,548
+12,206
+23% +$874K
PCH
1247
DELISTED
PotlatchDeltic
PCH
$4.5M 0.01%
111,915
-111,781
-50% -$4.66M
EPD icon
1248
Enterprise Products Partners
EPD
$81.2B
$4.47M 0.01%
110,989
+13,471
+14% +$529K
MCA
1249
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$4.45M 0.01%
305,630
+8,265
+3% +$120K
O icon
1250
Realty Income
O
$58.2B
$4.42M 0.01%
111,965
+5,682
+5% +$242K

Similar funds

Guggenheim Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Guggenheim Capital held 3,328 positions worth $41.7B, up 5.5% from $39.5B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Guggenheim Capital's Q3 2014 filing shows 131 new, 1,345 increased, 1,491 reduced and 336 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M. The largest sale was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, an estimated $98.4M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Guggenheim Capital's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 470,475 shares worth $17.5M.
  • Guggenheim Capital added most to CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF in Q3 2014, an estimated $96.3M increase.
  • Guggenheim Capital's biggest Q3 2014 reduction was GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF, cutting an estimated $98.4M.
  • Guggenheim Capital fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $40.1M.
  • Guggenheim Capital's ten largest holdings make up 9.5% of its $41.7B portfolio in Q3 2014.
  • Guggenheim Capital opened 131 new positions and closed 336 in Q3 2014.
  • Guggenheim Capital's portfolio value rose 5.5% quarter-over-quarter to $41.7B.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.